Understanding how brain aging outside stroke injury zones affects aphasia
After a stroke, even areas of the brain that are not directly impacted by the injury can show signs of accelerated aging.
another news portal
After a stroke, even areas of the brain that are not directly impacted by the injury can show signs of accelerated aging.
Imagine swimmers on starting blocks poised to dive at the sound of the starting horn or the driver of a car going 60 mph suddenly
There is no treatment available today to stop the death of brain cells in neurodegenerative diseases known as tauopathies, including Alzheimer’s disease, in which twisted
The British Medical Association is in dispute with Manx Care over “pay erosion since 2008”.
Cambridge scientists say they have, for the first time, tested a vaccine designed by AI.
Patients preparing for pancreatic cancer surgery maintained better physical function and experienced less fatigue with five treatments of stereotactic body radiation therapy (SBRT) than with
Researchers analyzed dietary data from 204,938 UK Biobank participants and identified blood protein and metabolite profiles associated with adherence to the EAT-Lancet diet. These profiles
In a discrete choice experiment involving 272 Dutch adults, researchers examined how people valued meat, meat replacers, and legumes across pasta and traditional potatoes-meat-vegetables meals.
CVD remains the leading cause of death worldwide, while the global burden of mental disorders continues to rise.
The most dramatic shift in human communication patterns in history is underway – the migration of social life onto screens – and researchers have issued
Aging progressively affects the functioning of our body and, among other things, deteriorates the ability of the hematopoietic system- the set of organs and tissues
The review examines how AI combines molecular, imaging, circulating, cellular, and digital data to identify potential disease biomarkers. Its authors argue that independent validation, biological
A recent analysis of the NRG-RTOG 0534 “SPPORT” clinical trial evaluated the Luminal B (LumB) molecular subtype using the PAM50 genomic classifier to determine whether
Sir Andrew Dilnot, who proposed reforms 15 years ago, says the cost of such a scheme would be “very substantial”.